Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Maintains Outperform on Baxter Intl, Lowers Price Target to $66

Raymond James Maintains Outperform on Baxter Intl, Lowers Price Target to $66

Raymond James analyst Jayson Bedford maintains Baxter Intl (NYSE:BAX) with a Outperform and lowers the price target from $85 to $66.

byBenzinga Newsdesk

July 29, 2022

1 minute read

Raymond James analyst Jayson Bedford maintains Baxter Intl (NYSE:BAX) with a Outperform and lowers the price target from $85 to $66.

Goldman Sachs Maintains Neutral on Entrada Therapeutics, Raises Price Target to $13

By Benzinga Newsdesk

August 16, 8:40 AM

Goldman Sachs analyst Chris Shibutani maintains Entrada Therapeutics (NASDAQ:TRDA) with a Neutral and raises the price target from $10 to $13.

TRDA

Spain’s Ferrovial To Build Microsoft Data Center In Madrid

By Anusuya Lahiri

January 3, 10:14 AM

Microsoft Corp (NASDAQ:MSFT) has authorized Spain-based infrastructure company Ferrovial SA (OTC:FRRVY) to build a data center near the Spanish capital. The contract could…

FRRVY

US Silica Holdings: Q2 Earnings Insights

By Benzinga Insights

July 29, 6:53 AM

US Silica Holdings (NYSE:SLCA) reported its Q2 earnings results on Friday, July 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

SLCA